【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2013 15
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q4 2013 15
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q4 2013 18
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q4 2013 19
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q4 2013 20
2.4.1 McKesson to Acquire Celesio for US$8.49 Billion 20
2.4.2 AstraZeneca to Acquire Remaining 50% Interest in Diabetes Joint Venture from Bristol-Myers Squibb for US$4.3 Billion 22
2.4.3 Shire Completes Acquisition of Majority Interest in ViroPharma for US$2.7 Billion 23
2.4.4 Johnson & Johnson Prices Public Offering of Notes for US$3.5 Billion 24
2.4.5 OncoMed Pharma Enters Into Co-Development Agreement with Celgene 24
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 26
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q4 2013 26
3.1.1 Top M&A Deals in Q4 2013 27
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q4 2012 – Q4 2013 28
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q4 2013 30
3.2.1 Top Initial Public Offerings in Q4 2013 32
3.2.2 Top Secondary Offerings in Q4 2013 32
3.2.3 Top PIPE Deals in Q4 2013 32
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q4 2012-Q4 2013 33
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q4 2012 – Q4 2013 34
3.2.6 Top Venture Financing Deals in Q4 2013 36
3.2.7 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2013 37
3.2.8 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2013 38
3.2.9 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q4 2012 – Q4 2013 39
3.2.10 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q4 2012 – Q4 2013 41
3.2.11 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q4 2012 – Q4 2013 43
3.3 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q4 2013 44
3.3.1 Top Private Equity Deals in Q4 2013 45
3.3.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q4 2012 – Q4 2013 46
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2013 48
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2013 48
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q4 2012 – Q4 2013 50
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 52
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q4 2013 53
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q4 2013 54
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q4 2013 55
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2012 – Q4 2013 56
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q4 2012 – Q4 2013 58
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q4 2012 – Q4 2013 59
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2012 – Q4 2013 61
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2013 63
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q4 2013 63
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2012 – Q4 2013 65
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q4 2013 67
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q4 2013 67
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q4 2013 68
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q4 2012 – Q4 2013 69
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q4 2012 – Q4 2013 71
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2012 – Q4 2013 73
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2012 – Q4 2013 74
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q4 2012 – Q4 2013 76
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 78
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q4 2012 – Q4 2013 78
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q4 2012 – Q4 2013 80
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q4 2012 – Q4 2013 82
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q4 2012 – Q4 2013 84
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q4 2012 – Q4 2013 86
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q4 2012 – Q4 2013 88
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q4 2012 – Q4 2013 90
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 92
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q4 2013 92
7.1.1 Oncology – Deals of the Quarter 94
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q4 2013 97
7.2.1 Central Nervous System – Deals of the Quarter 99
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q4 2013 101
7.3.1 Infectious Disease – Deals of the Quarter 103
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q4 2013 104
7.4.1 Immunology – Deals of the Quarter 106
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q4 2013 107
7.5.1 Metabolic Disorders – Deals of the Quarter 109
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q4 2013 111
7.6.1 Cardiovascular – Deals of the Quarter 113
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q4 2013 115
7.7.1 Gastrointestinal – Deals of the Quarter 117
7.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q4 2013 119
7.8.1 Dermatology – Deals of the Quarter 121
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q4 2013 122
7.9.1 Respiratory – Deals of the Quarter 124
7.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q4 2013 126
7.10.1 Ophthalmology – Deals of the Quarter 128
8 Deal Summary by Geography 129
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q4 2013 129
8.1.1 North America – Deals of the Quarter 131
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q4 2013 134
8.2.1 Europe – Deals of the Quarter 136
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q4 2013 139
8.3.1 Asia-Pacific – Deals of the Quarter 141
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q4 2013 143
8.4.1 Rest of the World – Deals of the Quarter 145
9 Pharmaceuticals & Healthcare, Global, Top Advisors 146
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 146
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 148
10 Appendix 150
11 Further Information 154
11.1 Methodology 154
11.2 About GlobalData 155
11.3 Disclosure information 156
11.4 Disclaimer 156
【レポート販売概要】
■ タイトル：グローバル製薬業界における事業提携、ライセンシング、投資及びM&A動向：Q4 2013■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2013
■ 発行日：2014年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDPH0441QD
■ 調査対象地域：グローバル
- グリースの世界市場2019-2023123 pages, November 2018 About this market The bio-based grease products are expected to gain traction in the grease market during the forecast period owing to their eco-friendly characteristics. These products have emerged as a reliable substitute to petroleum-based grease products. The grease market will witness an incremental growth close to USD264 million during 2019-2023. Market Overview Grow …
- 量子ドットの世界市場2015-2019About quantum dots Quantum dots are made up of semiconductor materials and are one of the emerging sub-technologies in the area of nanotechnology. Quantum dots have small dimension and exhibit excellent optical properties when excited. When quantum dots are excited with energy, they emit light fluorescence or electronics of different intensities which depends on the tuning and size of the quantum …
- モータ用ソフトスタータの世界市場予測及び動向Soft starters have several applications; they are primarily used in applications with limited installation space such as in the oil & gas, mining, and power generation industries where uncontrolled motor acceleration can damage the motor and affect the entire process, leading to monetary losses for the company. The device can be installed with fans, pumps, compressors, and other equipment to contr …
- 世界の対IED防衛市場動向2013-2023：トレンド、開発動向及び課題Technological Developments in the global Counter IED include: ■ The Vehicle Global Acceleration Mitigation (VGAM) and Vehicle Armored Floor Stabilization (VAFS) systems being developed by the UK. ■ Software to predict where IED attacks will take place and locate weapons caches. ■ The US Navy has developed a radio-frequency energy to detonate hidden IEDs. ■ US Navy developing the next generation co …
- フィットネスバンドの世界市場2015-2019Fitness band is a wristband used to monitor and track fitness-related metrics. It helps in tracking the duration of sleep, calories consumed/burnt, distance walked, heart rate, and various other activities. It is possible to sync this device with mobile devices to get a periodic statistics of activities to users. Some of the fitness bands may also have additional features such as notification of i …
- 世界の顧客経験管理市場動向（2012-2016）TechNavio's analysts forecast the Global Customer Experience Management (CEM) market to grow at a CAGR of 20.79 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased number of customer touch points. The Global CEM market has also been witnessing a growing demand for mobile analytics. However, integration of multiple communication channels cou …
- 機械式灌漑システムの世界市場：センターピボット灌漑、平行移動式灌漑、定置式灌漑The mechanized irrigation systems market has grown exponentially in the last few years and this trend is projected to continue. The market was valued at $2,070.21 million in 2013 and is projected to grow at a CAGR of 15.3% during 2014 to 2019. Rising population, increasing food requirements, increasing awareness among farmers regarding the benefits of mechanized irrigation systems, low cost of irr …
- 世界のタブレットPC用プロセッサ市場動向Tablet growth has been stagnant and the global market for tablets is near saturation. This is evidence by the fact that tablet sales of two leading brands Apple and Samsung have been losing shine. The market growth now weighs more on cheaper tablets of Chinese and white-box vendors. The trend toward lower-cost has forced tablet vendors to change their minds about processor adoption. This has led t …
- ヘルスケア/医療シミュレーション製品・サービスの世界市場予測（～2021年）The global medical simulation market is projected to reach USD 2.27 Billion by 2021, at a CAGR of 15.2% from 2016 to 2021. The market growth can be attributed to a number of factors such as increasing healthcare costs, rising focus on patient safety, and technological advancements. Increasing demand for minimally invasive treatments and increasing consolidation of the market players are other majo …
- キノコ缶詰の世界市場2019-2023About this market Packaging innovations to drive market growth. Packaging plays a major role in the sales of canned mushrooms, in terms of retaining the flavor, taste, product quality, color, texture, and shelf life. Many major companies are collaborating with packaging manufacturers to develop advanced packaging technology for their products to expand their consumer base. The packaging of any pro …
- ネットワークエミュレータの世界市場予測（～2024年）Global network emulator market to grow at a CAGR of 8.1% during the forecast period The global network emulator market size to grow from USD 146 million in 2019 to USD 217 million by 2024, at a Compound Annual Growth Rate (CAGR) of 8.1% during 2019–2024. Rise of attacks and security breaches on networks, and the need for reduced downtime in networking are the major factors driving the network emul …
- ジョッキーボックスの世界市場2018-2022About Jockey Boxes Jockey boxes are cooling containers with long coils of hollow tubing immersed in ice and water. They are used to cool beverages such as beer, coffee, and wine served at locations where refrigerators are not available. Technavio’s analysts forecast the global jockey boxes market to grow at a CAGR of 6.20% during the period 2018-2022. Covered in this report The report covers the p …
- 金属および金属製造産業用ガスの世界市場予測（～2020）MarketsandMarkets projects that the industrial gases in metals & metal fabrication market is projected to grow from USD 35.05 Billion in 2015 to USD 47.06 Billion by 2020, at a CAGR of 6.07%. The industrial gases in metals & metal fabrication market is projected to grow as a result of increasing demand in metal industry due to rising urbanization, continuous economic development in emerging econom …
- ナノ粒子 – 金属および金属酸化物の世界市場分析：タイプ別（金、銀、酸化鉄、アルミナ、ガドリニウム、セリウム）、用途別（インビボイメージング、標的薬物送達、プロトン療法、インビトロアッセイ）、セグメント予測、2013-2025The global nanoparticles - metal & metal oxides market in healthcare is anticipated to reach USD 80.74 billion by 2025, according to a new report by Grand View Research, Inc. Several nanotechnologies based medicines have been put forward for approval by the FDA which is anticipated to propel growth. Success of nanomedicine has prompted the development of enhanced nanomaterials for clinical applica …
- レアガス（希ガス）の世界市場：ネオン、キセノン、クリプトンThe rare gases market is projected to reach USD 380.9 Million by 2020, at a CAGR of 7.68%, from 2015. Growth in construction, lighting, and laser applications, increasing energy prices, and rapid urbanization has fueled the growth of the rare gases market. The illumination segment held the largest share of the total rare gases market in 2014, especially in emerging markets such as China, Brazil, a …
